Zhihuang G. Hu
651 Dongfeng East Road
Guangzhou, 510060, China
Guangzhou, 510060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 68 publications
68Ga-granzyme B (68Ga-NOTA-GSI) PET/CT for predicting immunotherapy response and progression free survival in NSCLC.
Journal: European journal of nuclear medicine and molecular imaging
Published: April 09, 2026
Precision palliative care in advanced/recurrent esophageal cancer patients treated with anti-PD-1/PD-L1 immunotherapy (ESO-Shanghai 25): a randomized, phase III Trial.
Journal: Future oncology (London, England)
Published: March 04, 2026
Membrane protein-focused CRISPR screen identifies ATP2A2 as a druggable transcriptional co-regulator of CCND1 (cyclin D1) in lung adenocarcinoma.
Journal: Life sciences
Published: November 02, 2025
Real-world outcomes of trastuzumab deruxtecan as second- or further-line treatment in patients with HER2-mutant metastatic non-small cell lung cancer: a retrospective study.
Journal: Translational lung cancer research
Published: August 06, 2025
BRD9-p53-E2F1 circuit orchestrates cell growth and DNA damage repair in gastric cancer.
Journal: Molecular cancer
Published: June 23, 2025
Evaluation of gefitinib alone or combined with bevacizumab in patients with EGFR L858R-positive advanced non-squamous non-small cell lung cancer: an open-label, randomized, phase 2 trial (BEVA-FLFX-001) with exploratory analysis of plasma biomarkers.
Journal: Translational lung cancer research
Published: May 08, 2025
The Spatial Proximity of CD8+ FoxP3+PD-1+ Cells to Tumor Cells: A More Accurate Predictor of Immunotherapy Outcomes in Advanced Non-Small-Cell Lung Cancer.
Journal: Current oncology (Toronto, Ont.)
Published: March 07, 2025
Small extracellular vesicle miRNAs as biomarkers for predicting antitumor efficacy in lung adenocarcinoma treated with chemotherapy and checkpoint blockade.
Journal: Frontiers in immunology
Published: February 08, 2025
Maintenance therapy for metastatic non-squamous non-small cell lung cancer: efficacy and biomarker analysis of pemetrexed discontinuation.
Journal: Translational lung cancer research
Published: January 05, 2025
EGFR inhibitors plus dabrafenib and trametinib in patients with EGFR-mutant lung cancer and resistance mediated by BRAFV600E mutation: a multi-center real-world experience in China.
Journal: Translational lung cancer research
Published: September 04, 2024
Glyco-signatures in patients with advanced lung cancer during anti-PD-1/PD-L1 immunotherapy.
Journal: Acta biochimica et biophysica Sinica
Published: July 02, 2024
Identification of a prognostic gene signature in patients with cisplatin resistant squamous cell lung cancer.
Journal: Journal of thoracic disease
Published: May 18, 2024
Last Updated: 09/26/2026